Red Lake Nation News - Babaamaajimowinan (Telling of news in different places)

Under fire over high prices, Eli Lilly promised cheaper insulin in 2019. The result has some senators steamed.


December 30, 2019

Dispatch file photo/Dispatch – Columbus Dispatch

Rising costs have caused almost half of diabetics occasionally to skip taking their insulin, according to a 2018 survey.

WASHINGTON – Each year brings a fresh episode of popular and political outrage overhigh drug prices. In 2019, it was insulin's turn in the spotlight.

The lifesaving drug for diabetics surged in list price more than 250 percent over a recent 10-year span - despite being a century-old invention. The three largest manufacturers, one American and two European, were accused of excessively pricing their drugs. The media featured stories of patients rationing their insulin, sometimes with fatal results.


Reader Comments


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2019